Related Experiment Video

Updated: Aug 23, 2026

Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins
07:20

Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins

Published on: June 14, 2018

Naked RNA vaccine controls tumors with down-regulated MHC class I expression through NK cells and perforin-dependent

Wen-Fang Cheng1, Chien-Fu Hung, Chien-Nan Lee

  • 1Department of Obstetrics and Gynecology, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.

European Journal of Immunology
|June 24, 2004
PubMed

Insights

This study shows that naked RNA vaccines can effectively combat tumors with down-regulated MHC class I expression. Natural killer (NK) cells are crucial for these antitumor effects, particularly in perforin-dependent pathways.

Area of Science:

  • Immunology
  • Oncology
  • Virology

Background:

  • Many human cancers reduce MHC class I expression, a challenge for cancer immunotherapy.
  • Understanding anti-tumor mechanisms against these cancers is key for developing effective vaccines and therapies.

Purpose of the Study:

  • To investigate the anti-tumor effects of naked Sindbis RNA replicon vaccines against tumors with down-regulated MHC class I expression.
  • To elucidate the mechanisms underlying these anti-tumor effects, focusing on the role of natural killer (NK) cells.

Main Methods:

  • Utilized a naked Sindbis RNA replicon vector (SINrep5) encoding herpes simplex virus type 1 protein VP22 linked to E7 (SINrep5-VP22/E7).
  • Administered naked SINrep5 RNA vaccines to tumor models with varying MHC class I expression.
  • Conducted in vivo antibody depletion experiments to assess the role of NK cells and perforin.

Main Results:

  • SINrep5-VP22/E7 demonstrated significant anti-tumor effects against tumors with down-regulated MHC class I.
  • Naked SINrep5 RNA and E7 vaccines showed effects against specific tumor types.
  • Vaccination increased NK cell percentages, which were vital for anti-tumor responses against MHC class I-down-regulated tumors.
  • Anti-tumor effects were perforin-dependent, and Poly I:C also enhanced NK cell activity.

Conclusions:

  • The SINrep5-VP22/E7 naked RNA vaccine effectively targets both MHC class I-positive and MHC class I-down-regulated tumor cells through distinct mechanisms.
  • Natural killer (NK) cells play a critical role in the anti-tumor efficacy of naked RNA replicon vaccines.

More Related Videos

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...